• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>History and Technology >Patents and public health in France. Pharmaceutical patent law in-the-making at the patent office between the two world wars
【24h】

Patents and public health in France. Pharmaceutical patent law in-the-making at the patent office between the two world wars

机译：法国的专利和公共卫生。两次世界大战之间专利局正在制定药品专利法

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

France excluded the patentability of pharmaceutical products for a long time, from 1844 to 1960. Yet, even though there was no change in the legal norm relative to drug patents, during the inter-war period the national patent office (ONPI) examined applications for pharmaceutical patents and issued a growing number of process patents on an increasingly broad range of health products. This article analyses the making of patent law by the Comit Technique de la Proprit Industrielle, comprised of jurists, patent engineers, industrialists and professors in pharmacy. The committee produced its own corpus of rules for examining patent applications, which superseded the law. This committee's work led to two significant developments: a growth in the number of pharmaceutical process patents between 1920 and 1939, and the inclusion of biological product preparations (hormones, vaccines, serums) into the patent sphere.
机译：法国在1844年至1960年的很长一段时间内一直在排除药品的可专利性。但是，即使相对于药品专利的法律规范没有变化，在两次世界大战期间，国家专利局（ONPI）仍在审查专利申请。越来越多的保健产品获得制药专利并颁发了越来越多的工艺专利。本文分析了工业产权委员会（Comit Technique de la Proprit Industrielle）制定的专利法，该法由法学家，专利工程师，工业家和药学教授组成。该委员会制定了自己的专利审查规则集，以取代法律。该委员会的工作取得了两个重大进展：1920年至1939年间制药工艺专利数量的增长，以及生物制品的制备（激素，疫苗，血清）进入专利领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号